drugset / Trial / NCT04183114
Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)
RandomizedParallel-groupTriple-blindPrevention
Summary
Thus study is a clinical trial for Measles and Rubella vaccine that will be used inIndonesian National Program of Immunization. The study design will be randomized, observer blind, prospective intervention study.
Timeline
- Start
- 2019-09-03
- Primary completion
- 2019-11-11
- Completion
- 2019-11-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | MR Vaccine SII | Vaccine | — | — |
| Subject | Measles-Rubella vaccine Bio Farma | Vaccine | — | — |